IRIS Accounts Production v24.3.0.553 SC062673 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC0626732023-09-30SC0626732024-09-30SC0626732023-10-012024-09-30SC0626732022-09-30SC0626732022-10-012023-09-30SC0626732023-09-30SC062673ns15:Scotland2023-10-012024-09-30SC062673ns14:PoundSterling2023-10-012024-09-30SC062673ns10:Director12023-10-012024-09-30SC062673ns10:PrivateLimitedCompanyLtd2023-10-012024-09-30SC062673ns10:SmallEntities2023-10-012024-09-30SC062673ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-30SC062673ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-30SC062673ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-30SC062673ns10:FullAccounts2023-10-012024-09-30SC062673ns10:Director22023-10-012024-09-30SC062673ns10:Director32023-10-012024-09-30SC062673ns10:CompanySecretary12023-10-012024-09-30SC062673ns10:RegisteredOffice2023-10-012024-09-30SC062673ns5:CurrentFinancialInstruments2024-09-30SC062673ns5:CurrentFinancialInstruments2023-09-30SC062673ns5:Non-currentFinancialInstruments2024-09-30SC062673ns5:Non-currentFinancialInstruments2023-09-30SC062673ns5:ShareCapital2024-09-30SC062673ns5:ShareCapital2023-09-30SC062673ns5:RetainedEarningsAccumulatedLosses2024-09-30SC062673ns5:RetainedEarningsAccumulatedLosses2023-09-30SC062673ns5:PlantMachinery2023-10-012024-09-30SC062673ns5:FurnitureFittings2023-10-012024-09-30SC062673ns5:ComputerEquipment2023-10-012024-09-30SC062673ns5:PlantMachinery2023-09-30SC062673ns5:FurnitureFittings2023-09-30SC062673ns5:ComputerEquipment2023-09-30SC062673ns5:PlantMachinery2024-09-30SC062673ns5:FurnitureFittings2024-09-30SC062673ns5:ComputerEquipment2024-09-30SC062673ns5:PlantMachinery2023-09-30SC062673ns5:FurnitureFittings2023-09-30SC062673ns5:ComputerEquipment2023-09-30SC062673ns5:CostValuation2023-09-30SC062673ns5:DisposalsRepaymentsInvestments2024-09-30SC062673ns5:CostValuation2024-09-30SC062673ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-30SC062673ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30SC062673ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-09-30SC062673ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-09-30SC062673ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-09-30SC062673ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-09-30SC062673ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-09-30SC062673ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-09-30SC062673ns5:Secured2024-09-30SC062673ns5:Secured2023-09-30SC062673ns10:Director222023-09-30SC062673ns10:Director222022-09-30SC062673ns10:Director222023-10-012024-09-30SC062673ns10:Director222022-10-012023-09-30SC062673ns10:Director222024-09-30SC062673ns10:Director222023-09-30SC0626733ns10:Director32023-09-30SC0626733ns10:Director32022-09-30SC0626733ns10:Director32023-10-012024-09-30SC0626733ns10:Director32022-10-012023-09-30SC0626733ns10:Director32024-09-30SC0626733ns10:Director32023-09-30
REGISTERED NUMBER: SC062673 (Scotland)















Unaudited Financial Statements for the Year Ended 30 September 2024

for

Baymed Healthcare Ltd

Baymed Healthcare Ltd (Registered number: SC062673)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Baymed Healthcare Ltd

Company Information
for the Year Ended 30 September 2024







DIRECTORS: Ms R Dover
M Simpson
S Donegan





SECRETARY: Ms R Dover





REGISTERED OFFICE: Unit J
No 1 Glenburn Road
East Kilbride
Glasgow
G74 5BA





REGISTERED NUMBER: SC062673 (Scotland)





ACCOUNTANTS: Accountants Plus
Chartered Certified Accountants
Unit 1 Cadzow Park
82 Muir Street
Hamilton
ML3 6BJ

Baymed Healthcare Ltd (Registered number: SC062673)

Balance Sheet
30 September 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 10,525 9,297
Investments 5 - 3
10,525 9,300

CURRENT ASSETS
Stocks 221,732 105,764
Debtors 6 517,921 444,547
Cash at bank and in hand 226 138,044
739,879 688,355
CREDITORS
Amounts falling due within one year 7 639,840 545,944
NET CURRENT ASSETS 100,039 142,411
TOTAL ASSETS LESS CURRENT
LIABILITIES

110,564

151,711

CREDITORS
Amounts falling due after more than
one year

8

37,207

83,722
NET ASSETS 73,357 67,989

CAPITAL AND RESERVES
Called up share capital 200 100
Retained earnings 73,157 67,889
73,357 67,989

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Baymed Healthcare Ltd (Registered number: SC062673)

Balance Sheet - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 November 2024 and were signed on its behalf by:





Ms R Dover - Director


Baymed Healthcare Ltd (Registered number: SC062673)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

Baymed Healthcare Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on cost
Fixtures and fittings - 20% on cost
Computer equipment - 20% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Creditors
Short term creditors are measured at transaction price, less any impairment. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Cash and bank balances
Cash and bank balances are measured at the transaction price.


Baymed Healthcare Ltd (Registered number: SC062673)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2023 - 5 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 October 2023 30,648 44,435 57,811 132,894
Additions - - 6,270 6,270
At 30 September 2024 30,648 44,435 64,081 139,164
DEPRECIATION
At 1 October 2023 24,232 44,146 55,219 123,597
Charge for year 1,901 142 2,999 5,042
At 30 September 2024 26,133 44,288 58,218 128,639
NET BOOK VALUE
At 30 September 2024 4,515 147 5,863 10,525
At 30 September 2023 6,416 289 2,592 9,297

Baymed Healthcare Ltd (Registered number: SC062673)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 October 2023 3
Disposals (3 )
At 30 September 2024 -
NET BOOK VALUE
At 30 September 2024 -
At 30 September 2023 3

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 496,597 429,366
Directors' current accounts 17,970 14,998
Prepayments 3,354 183
517,921 444,547

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Bank loans and overdrafts 21,983 12,531
Trade creditors 382,731 208,442
Tax 52,477 29,363
VAT 28,907 20,238
Other creditors - 63,006
Directors' current accounts 84,675 91,218
Accrued expenses 69,067 121,146
639,840 545,944

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
30.9.24 30.9.23
£    £   
Bank loans - 1-2 years 12,531 12,531
Bank loans - 2-5 years 24,676 37,593
Bank loans more 5 yr by instal - 33,598
37,207 83,722

Baymed Healthcare Ltd (Registered number: SC062673)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
30.9.24 30.9.23
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 33,598

9. SECURED DEBTS

The following secured debts are included within creditors:

30.9.24 30.9.23
£    £   
Bank loans 49,738 96,253

The bank loan is secured by a bond and floating charge over the assets of the company. In addition, the bank loan is secured by a guarantee of £135,000 from one of the company's directors, R. Dover.

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2024 and 30 September 2023:

30.9.24 30.9.23
£    £   
M Simpson
Balance outstanding at start of year - -
Amounts advanced 17,970 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 17,970 -

S Donegan
Balance outstanding at start of year 14,998 (1,225 )
Amounts advanced (27,028 ) 16,223
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (12,030 ) 14,998